Ginkgo Bioworks reports Q2 EPS (9c), consensus (8c)

Reports Q2 revenue $81M, consensus $71.58M. “I’m really energized by the work that we have done at Ginkgo this past quarter,” said Jason Kelly, CEO. “This has been a record quarter on several dimensions, we launched more programs than we ever have before and are seeing strong output from our Foundry. While we still have much more to do, many of the investments we have made to make biology more like an engineering discipline are paying off. This is being reflected not only in our output but also in the outcomes we’re delivering for our partners, and we’re honored to have more and more technically sophisticated customers trusting Ginkgo to manage their R&D efforts.”